共 86 条
[71]
Stearns J.C., Lynch M.D.J., Senadheera D.B., Et al., Bacterial biogeography of the human digestive tract, Sci Rep, 1, (2011)
[72]
Li X.-X., Wong G.L.-H., To K.-F., Et al., Bacterial microbiota profiling in gastritis without Helicobacter pylori infection or non-steroidal anti-inflammatory drug use, PLoS One, 4, (2009)
[73]
Lofgren J.L., Whary M.T., Ge Z., Et al., Lack of commensal flora in H. pylori-infected INS-GAS mice reduces gastritis and delays intraepithelial neoplasia, Gastroenterology, 140, pp. 210.e4-220.e4, (2011)
[74]
Delgado S., Cabrera-Rubio R., Mira A., Et al., Microbiological survey of the human gastric ecosystem using culturing and pyrosequencing methods, Microbial Ecol, 65, pp. 763-772, (2013)
[75]
Biarc J., Nguyen I.S., Pini A., Et al., Carcinogenic properties of proteins with pro-inflammatory activity from Streptococcus infantarius (formerly S. bovis), Carcinogenesis, 25, pp. 1477-1484, (2004)
[76]
Dicksved J., Lindberg M., Rosenquist M., Et al., Molecular characterization of the stomach microbiota in patients with gastric cancer and in controls, J Med Microbiol, 58, pp. 509-516, (2009)
[77]
Yang I., Woltemate S., Piazuelo M.B., Et al., Different gastric microbiota compositions in two human populations with high and low gastric cancer risk in Colombia, Sci Rep, 6, (2016)
[78]
Lind T., Van Zanten S.V., Unge P., Et al., Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: The MACH I study, Helicobacter, 1, pp. 138-144, (1996)
[79]
Fischbach L., Evans E.L., Meta-analysis: The effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori, Aliment Pharm Therap, 26, pp. 343-357, (2007)
[80]
Venerito M., Krieger T., Ecker T., Et al., Meta-analysis of bismuth quadruple therapy versus clarithromycin triple therapy for empiric primary treatment of Helicobacter pylori infection, Digestion, 88, pp. 33-45, (2013)